As per ASX announcement dated 7 January 2019, Creso Pharma Limited (ASX: CPH) has signed a Letter of Intent with Ceyoka Health Private Limited, Srilanka’s leading medical distribution company, for geographical expansion of medicinal cannabis across the country. The initial plan is to obtain the required regulatory approvals for selling Cresco’s proprietary cannabis drug cannAFFORD® 50 via approved channels in Sri Lanka. The strategic partnership will further shift its focus towards innovative therapeutic drugs containing hemp extracts.
Creso Pharma is Australia’s based pharmaceutical company engaged in offering cannabis medicine and hemp- derived lifestyle products for the treatment of humans and animals. The portfolio is spread across five